VySpine has been given FDA 510(k) clearance for its posterior cervical thoracic system, the medical device company said Jan. 6.
VySpine's PCT system includes multiple implant options for the thoracic spine to offer versatility for surgeons.
The system is "the first of many highly differentiated systems being developed by VySpine," said Tom McLeer, CEO of VySpine. "Using new materials and creative surgeon input, we are building exceptional quality, flexibility and pricing into all our products. This is just the beginning of the exciting, innovative product launches scheduled for early 2022."